A polymorphism in the receptor gene of vitamin D (VDR) significantly influences reduction in osteoporosis risk, medical experts found, following the meta-analysis of results from 26 studies. The significance of this finding may allow physicians to innovate new diagnostic and treatment methods, aside from the traditional treatments involving bisphosphonates which have led to multi-district litigations regarding its side-effects, like Fosamax cases involving its manufacturer Merck.

The researchers found that people who possessed dual copies of the recessive b allele (bb genotype) for the VDR RS1544410 single nucleotide polymorphism (SNP) were 39 percent less likely to develop osteoporosis than those who presented having dual copies of the dominant allele B (BB genotype).

The same VDR was found to be responsible for influencing differences in bone mineral density and circulating osteocalcin levels in 1992.

(more…)

Nearly 500 lawsuits filed against some of the biggest bladder sling and mesh device manufacturers in the United States have reportedly led the Food and Drug Administration (FDA) to set a panel to reevaluate the safety and effectiveness of these devices in early September last year. Despite the rising number of injury complaints, some experts still think of a bladder sling device recall to be extreme as some women, if not all, may still benefit from these medical devices.

Based on the panel meeting, adverse event reports received by the FDA, and evaluated study findings, it has been reported that majority of the panel members is actually considering the recommendation that both surgical mesh and bladder sling devices used for the treatment of pelvic organ prolapse (POP) be reclassified from Class II (moderate-risk devices) to Class III (high-risk devices) because of issues concerning safety.

Bladder Sling Recall Video

Bladder Sling Recall

Sources:

bloomberg.com/news/2011-09-07/j-j-s-vaginal-mesh-to-be-weighed-by-fda-advisory-panel-as-lawsuits-climb.html
fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

Zoloft belongs to a group of medicine referred as selective serotonin reuptake inhibitor (SSRI). It is simply classified as an antidepressant but several studies discuss the potential harmful Zoloft side effects.

Birth defects are just some of the allegedly harmful side effects of Zoloft. Others include insomnia, tiredness, irritability, dizziness, confusion and headache. The most severe health complications brought about by Zoloft discontinuation are related to the heart, according to medical specialists.

Zoloft is manufactured by the pharmaceutical company Pfizer. Its generic name is setraline. According to media reports, Zoloft instantly became one of the largest-selling antidepressant drugs when it was released in the global market.

References:
·depression.emedtv.com/zoloft/zoloft-withdrawal.html
·depression.about.com/cs/sideeffects/a/maoiszoloft.htm

Zoloft Side Effects Lawsuit Video

Zoloft Lawsuit: Learn why you might want to file a Zoloft Lawsuit

Almost 50,000 patients who have had metal-on-metal hip replacements face increased checks amid fears they may cause serious health difficulties, orthopedic experts say. This will eventually lead to filing of a Stryker hip recall lawsuit if indeed there is really a problem.

The safety watchdog in the United Kingdom has increased vigilance on implants suspected of causing serious damage to muscle and bone from metal debris.

The friction between two metal plates in the body produces chemical fragments called ions that leak into the blood, triggering inflammation, and two to three times the predicted failure rate.

Hip replacements involve a ball, socket and stem, while the new alert relates to those whose replacements have a ball with a diameter of 36 millimeter or more.

Around 65,000 people in the UK have received metal on metal hip implants since 2003, of whom 49,000 are affected by because they have these ‘large-head’ implants. They have been told they should have annual tests on blood ion levels while those with symptoms will also need annual MRI scans.

Guidance published in 2010 said patients with large-head metal-on-metal implants should have annual checks for the first five years, but these have now been extended in keeping with the lifetime of the implant.

Source:
bbc.co.uk/news/health-17337993

There are mounting evidences showing that long-term use of Fosamax, a bone drug which is usually prescribed to post-menopausal women for the prevention of osteoporosis, may potentially cause brittle bones, increasing the risk of fractures, and also the incidences of osteonecrosis of the jaw according to media reports. The blog on Fosamax injury cases explains more on Fosamax-related health risks issues, most especially if it is used for more than five years.

The safety and effectiveness of Fosamax for the treatment of osteoporosis are based on clinical data of four years duration. The optimal duration of use has not been determined. All patients on Fosamax therapy should have the need for continued therapy re-evaluated on a periodic basis.

References:
well.blogs.nytimes.com/2012/05/09/new-cautions-about-long-term-use-of-bone-drugs/
drugs.com/pro/fosamax.html
health.harvard.edu/newsletters/Harvard_Womens_Health_Watch/2008/November/Whats_the_story_with_Fosamax

Fosamax Lawsuit Video

Fosamax Lawsuit – Would you benefit from legal action?

Treatment for depression usually consists of antidepressant.But it is significant to be careful of the possible dangers like Zoloft antidepressant birth defects on pregnant women who took this drug.Pregnant women are going through a great length of emotional mood including depression.Depression is a common tendency of pregnant women and alleviating the problem is important.

The risks and the benefits should be at par when a decision to take antidepressant is considered.A low percent of birth defects and relative pregnancy problems are generally reported associating antidepressants and pregnancy.There are few antidepressants that are thought to be harmful while some brands are considered safe.

Possible problems can consist of deformities of the fetus, lung complications, heart defects, insufficient weight at birth and incomplete developmental formation.But the associated risks are minimal as reflected in the previous medical research.Also significantly remember that changing of antidepressant medication should be referred to the patient’s doctor.Depression relapses and more possibility of developing congenital defects are at high risks when changes of antidepressant dosage or type is made during the last part of pregnancy.

Always think if taking antidepressant is more beneficial than the given possibilities of birth problems.Pregnant women who are under depression have another options like psychotherapies to help them recover from the condition.The possible choices should be talked about with the treating medical doctor.

Source: mayoclinic.com/health/antidepressants/DN00007